NCT06225596: An ongoing trial by BicycleTx Limited
This trial is ongoing. It must report results 6 years from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06225596 |
|---|---|
| Title | A Randomized Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 24, 2024 |
| Completion date | Dec. 31, 2030 |
| Required reporting date | Dec. 31, 2031, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |